002146.SZ
002146.SZ
CNE1000005Y9
RISESUN
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 35/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.2x as much as the broader market.

Beta (Market Relation)
1.24x
Above average
Volatility (5Y p.a.)
51.5% p.a.
5-Year Horizon
Max Drawdown (5Y)
-79.2%
5-Year Horizon
Sharpe Ratio
-0.50
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -21.6%
3 Years 51.2% -58.2% -0.31 -13.2%
5 Years 51.5% -79.2% -0.5 -23.4%
10 Years 44.5% -92.7% -0.42 -16.3%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 516%.
Unprofitable business model: The company is currently generating net losses.
Strong cyclicality: The business model is sensitive to economic downturns.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (51.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -92.7% in the extended horizon.
ende